Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6785 | 1367 | 34.9 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
796 | 11443 | DRY POWDER INHALER//MUCOADHESION//JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NASAL DELIVERY | Author keyword | 141 | 74% | 8% | 105 |
2 | NASAL DRUG DELIVERY | Author keyword | 113 | 71% | 7% | 91 |
3 | NASAL ABSORPTION | Author keyword | 91 | 70% | 6% | 76 |
4 | NASAL ADMINISTRATION | Author keyword | 48 | 52% | 5% | 65 |
5 | INTRANASAL DELIVERY | Author keyword | 20 | 39% | 3% | 40 |
6 | INTRANASAL ADMINISTRATION | Author keyword | 17 | 26% | 4% | 59 |
7 | BRAIN TARGETING | Author keyword | 15 | 26% | 4% | 50 |
8 | NASAL FORMULATION | Author keyword | 15 | 88% | 1% | 7 |
9 | ABSORPTION ENHANCERS | Author keyword | 14 | 38% | 2% | 30 |
10 | CILIOTOXICITY | Author keyword | 12 | 75% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NASAL DELIVERY | 141 | 74% | 8% | 105 | Search NASAL+DELIVERY | Search NASAL+DELIVERY |
2 | NASAL DRUG DELIVERY | 113 | 71% | 7% | 91 | Search NASAL+DRUG+DELIVERY | Search NASAL+DRUG+DELIVERY |
3 | NASAL ABSORPTION | 91 | 70% | 6% | 76 | Search NASAL+ABSORPTION | Search NASAL+ABSORPTION |
4 | NASAL ADMINISTRATION | 48 | 52% | 5% | 65 | Search NASAL+ADMINISTRATION | Search NASAL+ADMINISTRATION |
5 | INTRANASAL DELIVERY | 20 | 39% | 3% | 40 | Search INTRANASAL+DELIVERY | Search INTRANASAL+DELIVERY |
6 | INTRANASAL ADMINISTRATION | 17 | 26% | 4% | 59 | Search INTRANASAL+ADMINISTRATION | Search INTRANASAL+ADMINISTRATION |
7 | BRAIN TARGETING | 15 | 26% | 4% | 50 | Search BRAIN+TARGETING | Search BRAIN+TARGETING |
8 | NASAL FORMULATION | 15 | 88% | 1% | 7 | Search NASAL+FORMULATION | Search NASAL+FORMULATION |
9 | ABSORPTION ENHANCERS | 14 | 38% | 2% | 30 | Search ABSORPTION+ENHANCERS | Search ABSORPTION+ENHANCERS |
10 | CILIOTOXICITY | 12 | 75% | 1% | 9 | Search CILIOTOXICITY | Search CILIOTOXICITY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SODIUM TAURODIHYDROFUSIDATE | 62 | 92% | 2% | 24 |
2 | NASAL DRUG DELIVERY | 50 | 62% | 4% | 51 |
3 | INTRANASALLY ADMINISTERED INSULIN | 49 | 94% | 1% | 17 |
4 | NASAL ABSORPTION | 47 | 36% | 8% | 105 |
5 | DIRECT DRUG TRANSPORT | 27 | 92% | 1% | 11 |
6 | INTRANASAL DELIVERY | 25 | 39% | 4% | 51 |
7 | INTRANASAL DRUG DELIVERY | 22 | 81% | 1% | 13 |
8 | INSULIN IMPROVES MEMORY | 19 | 71% | 1% | 15 |
9 | CSF FOLLOWING INTRANASAL | 18 | 89% | 1% | 8 |
10 | ACID MIXED MICELLES | 17 | 70% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Intranasal Delivery to the Central Nervous System: Mechanisms and Experimental Considerations | 2010 | 207 | 141 | 48% |
Transport of drugs from the nasal cavity to the central nervous system | 2000 | 325 | 54 | 63% |
Intranasal delivery: Physicochemical and therapeutic aspects | 2007 | 156 | 245 | 45% |
Nanoparticles for direct nose-to-brain delivery of drugs | 2009 | 112 | 79 | 38% |
Intranasal Drug Delivery: How, Why and What for? | 2009 | 68 | 141 | 58% |
Physicochemical and physiological considerations for efficient nose-to-brain targeting | 2012 | 21 | 40 | 78% |
Intranasal delivery of biologics to the central nervous system | 2012 | 77 | 126 | 25% |
Nasal drug delivery - Recent developments and future prospects | 2012 | 25 | 48 | 63% |
Quantitative analysis of drug delivery to the brain via nasal route | 2014 | 8 | 22 | 50% |
Nasal route and drug delivery systems | 2004 | 107 | 47 | 87% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | W PHARMACEUT SERV | 4 | 36% | 0.6% | 8 |
2 | HEALTHPARTNERS FDN | 3 | 28% | 0.7% | 10 |
3 | FARMACOTECHNOL BIOFARM | 3 | 16% | 1.0% | 14 |
4 | EXPT OTORHINOLARYNGOL | 2 | 22% | 0.7% | 9 |
5 | BIOPHARMACEUT DRUG DELIVERY | 2 | 36% | 0.4% | 5 |
6 | PHARMACEUT SCI PHARMACEUT SHINJUKU KU | 2 | 67% | 0.1% | 2 |
7 | DRUG DELIVERY DEV | 1 | 50% | 0.1% | 2 |
8 | NUCL MED NMD | 1 | 100% | 0.1% | 2 |
9 | TURKISH MED MED DEVICES AGCY | 1 | 50% | 0.1% | 2 |
10 | TTS TECHNOL | 1 | 33% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000150756 | SODIUM CAPRATE//SUPPOSITORY//ABSORPTION ENHANCER |
2 | 0.0000138468 | MUCOADHESION//THIOMERS//BUCCAL DELIVERY |
3 | 0.0000126146 | INHALED INSULIN//PULMONARY ABSORPTION//PULMONARY DELIVERY |
4 | 0.0000110624 | ORAL DELIVERY//ORAL INSULIN DELIVERY//ORAL INSULIN |
5 | 0.0000109380 | RHINITIS MEDICAMENTOSA//TETRAHYDROZOLINE//RHINOSTEREOMETRY |
6 | 0.0000085464 | LIQUID SUPPOSITORY//POLOXAMER 407//POLOXAMER GEL |
7 | 0.0000074106 | BRAIN TARGETING//SMART DRUG DELIVERY//ANGIOPEP 2 |
8 | 0.0000072830 | NASAL IRRIGATION//SURG OTORHINOLARYNGOL HEAD NECK SURG//PULSATING AEROSOL |
9 | 0.0000070210 | OLFACTORY MUCOSA//BOWMANS GLANDS//BETA BETA IMINODIPROPIONITRILE IDPN |
10 | 0.0000064653 | N TRIMETHYL CHITOSAN CHLORIDE//CHITOSAN NANOPARTICLES//TRIPOLYPHOSPHATE |